Britain’s AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90 percent effective without any serious side effects, giving the world another important tool to halt the COVID-19 pandemic.

The vaccine developed by Oxford University was 90 percent effective in preventing COVID-19 when it was administered as a half dose followed by a full dose at least one month apart, according to data from the late-stage trials in Britain and Brazil.